Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Alpha-Beta Technology Inc.
Gregory Brown of Vector Securities International upgraded ABTI to "buy." Brown had lowered
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury